In conclusion, more in‐depth study of the complex inflammatory microenvironment may help to find new effective methods for the treatment of RA.[40, 41, 42, 43] The use of small interfering RNA (siRNA) to selectively reduce the production of pro‐inflammatory tumor necrosis factor has aroused considerable interest in the treatment of RA. The gene discussed is TNF; the disease is rheumatoid arthritis.